The highly anticipated results of a clinical trial for the pill, daraxonrasib, have been released, giving doctors hope for ...
Those taking daraxonrasib lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients.
Scientists at the world's largest cancer conference have hailed the start of a new drug 'revolution'.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results